| Recruiting | DESTINY-PANTUMOUR04 NCT07124000 | AstraZeneca | — |
| Recruiting | A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest NCT05899361 | Dana-Farber Cancer Institute | N/A |
| Recruiting | 64Cu-GRIP B in Patients With Advanced Malignancies NCT05888532 | Rahul Aggarwal | Phase 1 / Phase 2 |
| Unknown | MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour NCT03934827 | Imperial College London | Phase 1 |
| Recruiting | Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma NCT03291028 | Fox Chase Cancer Center | — |
| Completed | UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearch NCT02643043 | Matthew Milowsky, MD | N/A |
| Unknown | Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma NCT03296306 | Asan Medical Center | Phase 3 |
| Recruiting | Integrated Cancer Repository for Cancer Research NCT02012699 | University of Nebraska | — |
| Completed | Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other So NCT01352962 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patient NCT01191892 | Cardiff University | Phase 2 |
| Completed | Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relaps NCT01031875 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Phase 2 |
| Completed | Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Loc NCT01089088 | Cardiff University | Phase 2 |
| Completed | Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally NCT01090466 | Cardiff University | Phase 1 / Phase 2 |
| Active Not Recruiting | Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors NCT00479128 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium NCT00397488 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Unknown | Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Ur NCT01118039 | Hospital del Mar | Phase 2 |
| Completed | Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants NCT00900276 | Wake Forest University Health Sciences | — |
| Completed | Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium NCT00053209 | Eastern Cooperative Oncology Group | Phase 2 |
| Terminated | S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium NCT00087295 | SWOG Cancer Research Network | Phase 2 |
| Completed | Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium NCT00082719 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the U NCT00066612 | SWOG Cancer Research Network | Phase 2 |
| Active Not Recruiting | Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Aden NCT00082706 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Canc NCT00045630 | SWOG Cancer Research Network | Phase 2 |
| Completed | S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Tre NCT00055835 | SWOG Cancer Research Network | Phase 2 |
| Terminated | S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract NCT00022633 | SWOG Cancer Research Network | Phase 2 |
| Completed | Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radica NCT00080795 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer NCT00022191 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 |
| Completed | S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract NCT00014144 | SWOG Cancer Research Network | Phase 2 |
| Completed | Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Func NCT00005644 | Eastern Cooperative Oncology Group | Phase 2 |
| Completed | Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium NCT00014274 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 / Phase 3 |
| Completed | SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract NCT00006351 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Completed | Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract NCT00006026 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Completed | Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer NCT00004223 | Eastern Cooperative Oncology Group | Phase 2 |
| Completed | Combination Chemotherapy in Treating Patients With Bladder Cancer NCT00003701 | Eastern Cooperative Oncology Group | Phase 3 |
| Completed | Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tr NCT00006111 | UNICANCER | Phase 2 |
| Completed | Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With A NCT00003376 | Eastern Cooperative Oncology Group | Phase 3 |
| Completed | Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer NCT00003175 | Medical Research Council | Phase 2 |
| Completed | Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract NCT00002914 | Eastern Cooperative Oncology Group | Phase 2 |
| Completed | Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer NCT00002684 | Memorial Sloan Kettering Cancer Center | Phase 2 |